Zolpidem
Ambien, Edluar (zolpidem) is a small molecule pharmaceutical. Zolpidem was first approved as Ambien on 1992-12-16. It is used to treat sleep initiation and maintenance disorders in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1. In addition, it is known to target gamma-aminobutyric acid receptor subunit alpha-3 and gamma-aminobutyric acid receptor subunit alpha-2.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Ambien, Edluar (generic drugs available since 2007-04-23, discontinued: Intermezzo, Tovalt, Zolpimist)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
ambien | New Drug Application | 2019-02-12 |
edluar | New Drug Application | 2019-08-15 |
zolpidem tartrate | ANDA | 2023-06-08 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Zolpidem Tartrate, Zolpimist, Aytu | |||
8236285 | 2032-08-07 | DS, DP | U-70 |
Zolpidem Tartrate, Edluar, Mylan Speciality Lp | |||
9265720 | 2031-02-25 | U-674 | |
9597281 | 2027-04-06 | U-674 | |
Zolpidem Tartrate, Intermezzo, Purdue Pharma | |||
8242131 | 2029-08-20 | U-1266 | |
7658945 | 2027-04-15 | DP | U-1194 |
7682628 | 2025-02-16 | U-1194 | |
8252809 | 2025-02-16 | DP |
HCPCS
No data
Clinical
Clinical Trials
15 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | 5 | — | 3 | 3 | 1 | 12 |
Cluster headache | D003027 | HP_0012199 | G44.00 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Headache disorders | D020773 | EFO_0009550 | G44 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ZOLPIDEM |
INN | zolpidem |
Description | Zolpidem is an imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position. It has a role as a central nervous system depressant, a GABA agonist and a sedative. |
Classification | Small molecule |
Drug class | hypnotics/sedatives (zolpidem type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 |
Identifiers
PDB | — |
CAS-ID | 82626-48-0 |
RxCUI | 39993 |
ChEMBL ID | CHEMBL911 |
ChEBI ID | 10125 |
PubChem CID | 5732 |
DrugBank | DB00425 |
UNII ID | 7K383OQI23 (ChemIDplus, GSRS) |
Target
Agency Approved
GABRA1
GABRA1
Organism
Homo sapiens
Gene name
GABRA1
Gene synonyms
NCBI Gene ID
Protein name
gamma-aminobutyric acid receptor subunit alpha-1
Protein synonyms
GABA(A) receptor subunit alpha-1, GABA(A) receptor, alpha 1, gamma-aminobutyric acid (GABA) A receptor, alpha 1, gamma-aminobutyric acid type A receptor alpha1 subunit
Uniprot ID
Mouse ortholog
Gabra1 (14394)
gamma-aminobutyric acid receptor subunit alpha-1 (P62812)
Alternate
GABRA3
GABRA3
GABRA2
GABRA2
Organism
Homo sapiens
Gene name
GABRA3
Gene synonyms
NCBI Gene ID
Protein name
gamma-aminobutyric acid receptor subunit alpha-3
Protein synonyms
GABA(A) receptor subunit alpha-3, GABA(A) receptor, alpha 3, gamma-aminobutyric acid (GABA) A receptor, alpha 3, gamma-aminobutyric acid type A receptor alpha3 subunit, gamma-animobutyric acid (GABA) A receptor, alpha 3
Uniprot ID
Mouse ortholog
Gabra3 (14396)
gamma-aminobutyric acid receptor subunit alpha-3 (P26049)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 8,048 documents
View more details
Safety
Black-box Warning
Black-box warning for: Ambien , Edluar, Zolpidem tartrate
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
2,763 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more